Tailor Bio (formerly Pinpoint Oncology), is an oncology diagnostics company that is developing a proprietary precision oncology platform to identify patterns in tumour DNA to predict a patient’s response to cancer drugs.
News about Tailor Bio
Entrepreneurship and innovation
Why personal can be powerful when it comes to company values
Company values reflect a business’s principles to staff, recruiters, clients and investors – shaping office culture and driving growth. In this special Insight article, we talk to 4 ventures which have received support from Cambridge Judge Business School about what company values mean to them.
Student and alumni news
Can I start a new business during my MBA year?
Can I launch a business while studying for my MBA? How do I develop my ideas before taking the leap? What resources are available to budding entrepreneurs in Cambridge itself? We meet Cambridge MBA founders and alumni and ask them where their MBA led them and what steps they took to start their business and take the leap in their careers.
Insight
Startup innovation boost
£100,000-plus Innovate UK boost for two cutting-edge startups. The UK government recently announced that 800 innovative businesses and startups are set to benefit from Innovate UK funding. Two startups currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre at Cambridge Judge Business School – Tailor Bio and medwise.ai – are among the winners. Oncology diagnostics company Tailor Bio (formerly known as PinPoint Oncology) has secured £67,000 in funding for the Innovate UK category: application of whole-genome sequencing approaches to cancer. The venture is using machine learning to find patterns in tumour DNA which can be used to predict a person's response to cancer drugs. Their current test uses a biopsy of a patient's tumour to predict if they will respond to a drug used to treat ovarian cancer. Co-founder Jason Yip (MBA 2018) said: "I think that under normal circumstances, the startup journey is already incredibly difficult, and with COVID-19, this is made even harder. We're very privileged that the UK continues to support cutting-edge startups through Innovate UK. We're excited to receive this support from them, and hope to use the funding to advance precision medicine approaches to cancer." Medwise.ai has been awarded a UK government grant…